New hope for heart bypass patients: drug targets dangerous low blood pressure
Disease control
Not yet recruiting
This study tests a drug called Angiotensin II for patients who develop dangerously low blood pressure after heart bypass surgery. About 329 adults will receive the drug along with standard treatments, and their outcomes will be compared to similar patients from the past. The goal…
Phase: PHASE4 • Sponsor: Methodist Healthcare System of San Antonio • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC